Correlation between postoperative 3-[123I]iodo-L- α-methyltyrosine uptake and survival in patients with gliomas

Journal of Nuclear Medicine

Volumn 42, Issue 8, 2001, Pages 1144-1150

  Weber, W A ^a   Dick, S ^a   Reidl, G ^a   Dzewas, B ^a   Busch, R ^a   Feldmann, H J ^a   Molls, M ^a   Lumenta, C B ^a   Schwaiger, M ^a   Grosu, A L ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

3 123I iodo L methyltyrosine; Amino acid transport; Glioma; Prognosis

Indexed keywords

AMINO ACID DERIVATIVE; IODINE 123; METIROSINE; METIROSINE I 123; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DRUG UPTAKE; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; MALE; METHYLTYROSINES; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034894416     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: A quantitative dosimetric study
2. The role of radiosurgery for glial neoplasms
3. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model
4. Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
5. The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers
6. Targeting in gene therapy for gliomas
7. MR imaging of the brain: Tumors
8. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme
9. Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma
10. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference
11. 123I]iodo-alpha-methyl tyrosine and SPECT
12. 124JMT and first clinical results
13. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors
14. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine
15. 18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: A comparative study with stereotactic biopsy
16. First experience with 1-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas
17. Direct n.c.a. electrophilic radioiodination of tyrosine analogues: Their in vivo stability and brain-uptake in mice
18. F-18-fluorodeoxyglucose PET and I-123-alpha-methyl-tyrosine SPECT in the evaluation of brain tumors
19. A method for attenuation correction in radionuclide computed tomography
20. 3-Dimensional irradiation planning in brain tumors: The advantages of the method and the clinical results
21. 18F-deoxyglucose
22. Iodine-123-alpha-methyl tyrosine in gliomas: Correlation with cellular density and proliferative activity
23. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis
24. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials
25. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas
26. 11C]-L-methionine uptake in cerebral gliomas: A comparative study using SPECT and PET
27. 11C-methionine PET for differential diagnosis of low-grade gliomas
28. 11-methionine
29. Proliferative activity in human brain tumors: Comparison of histopathology and L-[1-(11)C]tyrosine PET
30. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodenxyglucose PET for the differentiation of astrocytic turnouts
31. Regional methionine and glucose uptake in high-grade gliomas: A comparative study on PET-guided stereotactic biopsy
32. 123]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells
33. 3H]methyl]-L-methionine
34. Methionine uptake by tumor tissue: A microautoradiographic comparison with FDG
35. 11CJtyrosine PET
36. New glycoprotein-associated amino acid transporters
37. 18FJfluoroethyl)-L-tyrosine for tumor imaging
38. 18F alpha-methyl tyrosine PET studies in patients with brain tumors